首页 > 最新文献

Health Services Research最新文献

英文 中文
Using social risks to predict unplanned hospital readmission and emergency care among hospitalized Veterans. 利用社会风险预测住院退伍军人的意外再入院和急诊护理。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-07 DOI: 10.1111/1475-6773.14353
Portia Y Cornell, Cassandra L Hua, Zachary M Buchalksi, Gina R Chmelka, Alicia J Cohen, Marguerite M Daus, Christopher W Halladay, Alita Harmon, Jennifer W Silva, James L Rudolph

Objectives: (1) To estimate the association of social risk factors with unplanned readmission and emergency care after a hospital stay. (2) To create a social risk scoring index.

Data sources and setting: We analyzed administrative data from the Department of Veterans Affairs (VA) Corporate Data Warehouse. Settings were VA medical centers that participated in a national social work staffing program.

Study design: We grouped socially relevant diagnoses, screenings, assessments, and procedure codes into nine social risk domains. We used logistic regression to examine the extent to which domains predicted unplanned hospital readmission and emergency department (ED) use in 30 days after hospital discharge. Covariates were age, sex, and medical readmission risk score. We used model estimates to create a percentile score signaling Veterans' health-related social risk.

Data extraction: We included 156,690 Veterans' admissions to a VA hospital with discharged to home from 1 October, 2016 to 30 September, 2022.

Principal findings: The 30-day rate of unplanned readmission was 0.074 and of ED use was 0.240. After adjustment, the social risks with greatest probability of readmission were food insecurity (adjusted probability = 0.091 [95% confidence interval: 0.082, 0.101]), legal need (0.090 [0.079, 0.102]), and neighborhood deprivation (0.081 [0.081, 0.108]); versus no social risk (0.052). The greatest adjusted probabilities of ED use were among those who had experienced food insecurity (adjusted probability 0.28 [0.26, 0.30]), legal problems (0.28 [0.26, 0.30]), and violence (0.27 [0.25, 0.29]), versus no social risk (0.21). Veterans with social risk scores in the 95th percentile had greater rates of unplanned care than those with 95th percentile Care Assessment Needs score, a clinical prediction tool used in the VA.

Conclusions: Veterans with social risks may need specialized interventions and targeted resources after a hospital stay. We propose a scoring method to rate social risk for use in clinical practice and future research.

目标:(1)估计社会风险因素与住院后意外再入院和急诊护理的关系。(2) 建立社会风险评分指数:我们分析了退伍军人事务部(VA)企业数据仓库中的管理数据。研究设计:我们将与社会相关的诊断、筛查、评估和程序代码归纳为九个社会风险领域。我们使用逻辑回归法来检验各领域对出院后 30 天内非计划再入院和急诊科(ED)使用的预测程度。协变量包括年龄、性别和医疗再入院风险评分。我们使用模型估计值创建了一个百分位数分数,以显示退伍军人与健康相关的社会风险:我们纳入了 2016 年 10 月 1 日至 2022 年 9 月 30 日期间入住退伍军人医院并出院回家的 156690 名退伍军人:30天意外再入院率为0.074,急诊室使用率为0.240。经调整后,再入院概率最大的社会风险是食物不安全(调整后概率=0.091 [95%置信区间:0.082,0.101])、法律需求(0.090 [0.079,0.102])和邻里贫困(0.081 [0.081,0.108]);而无社会风险(0.052)。那些经历过食物不安全(调整后概率为 0.28 [0.26, 0.30])、法律问题(0.28 [0.26, 0.30])和暴力(0.27 [0.25, 0.29])的退伍军人与无社会风险(0.21)的退伍军人相比,使用急诊室的调整后概率最大。与退伍军人事务部使用的临床预测工具 "护理评估需求评分"(Care Assessment Needs score)第 95 百分位数相比,社会风险评分在第 95 百分位数的退伍军人的计划外护理率更高:结论:有社会风险的退伍军人在住院后可能需要专门的干预措施和有针对性的资源。我们提出了一种评估社会风险的评分方法,供临床实践和未来研究使用。
{"title":"Using social risks to predict unplanned hospital readmission and emergency care among hospitalized Veterans.","authors":"Portia Y Cornell, Cassandra L Hua, Zachary M Buchalksi, Gina R Chmelka, Alicia J Cohen, Marguerite M Daus, Christopher W Halladay, Alita Harmon, Jennifer W Silva, James L Rudolph","doi":"10.1111/1475-6773.14353","DOIUrl":"10.1111/1475-6773.14353","url":null,"abstract":"<p><strong>Objectives: </strong>(1) To estimate the association of social risk factors with unplanned readmission and emergency care after a hospital stay. (2) To create a social risk scoring index.</p><p><strong>Data sources and setting: </strong>We analyzed administrative data from the Department of Veterans Affairs (VA) Corporate Data Warehouse. Settings were VA medical centers that participated in a national social work staffing program.</p><p><strong>Study design: </strong>We grouped socially relevant diagnoses, screenings, assessments, and procedure codes into nine social risk domains. We used logistic regression to examine the extent to which domains predicted unplanned hospital readmission and emergency department (ED) use in 30 days after hospital discharge. Covariates were age, sex, and medical readmission risk score. We used model estimates to create a percentile score signaling Veterans' health-related social risk.</p><p><strong>Data extraction: </strong>We included 156,690 Veterans' admissions to a VA hospital with discharged to home from 1 October, 2016 to 30 September, 2022.</p><p><strong>Principal findings: </strong>The 30-day rate of unplanned readmission was 0.074 and of ED use was 0.240. After adjustment, the social risks with greatest probability of readmission were food insecurity (adjusted probability = 0.091 [95% confidence interval: 0.082, 0.101]), legal need (0.090 [0.079, 0.102]), and neighborhood deprivation (0.081 [0.081, 0.108]); versus no social risk (0.052). The greatest adjusted probabilities of ED use were among those who had experienced food insecurity (adjusted probability 0.28 [0.26, 0.30]), legal problems (0.28 [0.26, 0.30]), and violence (0.27 [0.25, 0.29]), versus no social risk (0.21). Veterans with social risk scores in the 95th percentile had greater rates of unplanned care than those with 95th percentile Care Assessment Needs score, a clinical prediction tool used in the VA.</p><p><strong>Conclusions: </strong>Veterans with social risks may need specialized interventions and targeted resources after a hospital stay. We propose a scoring method to rate social risk for use in clinical practice and future research.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141556001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences across race and ethnicity in the quality of antidepressant medication management 不同种族和族裔在抗抑郁药物管理质量方面的差异。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-05 DOI: 10.1111/1475-6773.14347
Alex H. S. Harris PhD, MS, Pingyang Liu PhD, MS, Jessica Y. Breland PhD, Kenneth J. Nieser PhD, Eric M. Schmidt PhD

Objective

To illustrate the importance of a multidimensional view of disparities in quality of antidepressant medication management (AMM), as well as discriminating “within-facility” disparities from disparities that exist between facilities.

Data Sources and Study Setting

We used data from the Veterans Health Administration's (VA) Corporate Data Warehouse (CDW) which contains clinical and administrative data from VA facilities nationally.

Study Design

CDW data were used to measure five indicators of AMM quality, including the HEDIS Effective Acute-Phase and Effective Continuation-Phase measures. Mixed effects regression models were used to examine differences in quality indicators between racial/ethnic groups, controlling for other demographic and clinical factors. An adaptation of the Kitagawa-Blinder-Oaxaca (KBO) method was used to decompose mean differences in treatment quality between racial and ethnic groups into within- and between-facility effects.

Data Extraction Methods

Demographic, clinical, and health service utilization data were extracted for patients in fiscal year 2017 with a diagnosis of depression and a new start of an antidepressant medication.

Principal Findings

The decomposition of the overall differences between White and Black patients on receiving an initial 90-day prescription (46.7% vs. 32.7%), Effective Acute-Phase (79.7% vs. 66.8%), and Effective Continuation-Phase (64.0% vs. 49.6%) HEDIS measures revealed that most of the overall effects were “within-facility,” meaning that Black patients are less likely to meet these measures regardless of where they are treated. Although the overall magnitude of disparities between White and Hispanic patients on these three measures was very similar (46.7% vs. 32.7%; 79.7% vs. 69.2%; 64.0% vs. 53.6%), the differences were more attributable to Hispanic patients being treated in facilities with overall lower performance on these measures.

Conclusions

Discriminating within- and between-facility disparities and taking a multidimensional view of quality are essential to informing efforts to address disparities in AMM quality.

目的:说明从多维角度看待抗抑郁药物管理(AMM)质量差异的重要性,以及区分 "机构内 "差异和机构间差异的重要性:我们使用的数据来自退伍军人健康管理局(VA)的企业数据仓库(CDW),其中包含来自全国退伍军人机构的临床和行政数据:研究设计:CDW 数据用于衡量五项 AMM 质量指标,包括 HEDIS 有效急性期和有效持续期指标。在控制其他人口和临床因素的情况下,采用混合效应回归模型来检验种族/民族群体之间质量指标的差异。采用北川-布林德-瓦哈卡(Kitagawa-Blinder-Oaxaca,KBO)方法,将种族和民族群体间治疗质量的平均差异分解为设施内效应和设施间效应:提取了2017财年诊断为抑郁症并新开始使用抗抑郁药物的患者的人口统计学、临床和医疗服务使用数据:对白人和黑人患者在获得 90 天初始处方(46.7% 对 32.7%)、有效急性期(79.7% 对 66.8%)和有效持续期(64.0% 对 49.6%)HEDIS 指标方面的总体差异进行分解后发现,大部分总体影响是 "机构内 "的,这意味着黑人患者无论在哪里接受治疗,都不太可能达到这些指标。虽然白人和西班牙裔患者在这三项指标上的总体差距非常接近(46.7% vs. 32.7%;79.7% vs. 69.2%;64.0% vs. 53.6%),但这些差距更多是由于西班牙裔患者在这些指标上总体表现较差的医疗机构接受治疗造成的:结论:区分医疗机构内部和医疗机构之间的差异,并从多维角度看待医疗质量,对于解决医疗质量差异问题至关重要。
{"title":"Differences across race and ethnicity in the quality of antidepressant medication management","authors":"Alex H. S. Harris PhD, MS,&nbsp;Pingyang Liu PhD, MS,&nbsp;Jessica Y. Breland PhD,&nbsp;Kenneth J. Nieser PhD,&nbsp;Eric M. Schmidt PhD","doi":"10.1111/1475-6773.14347","DOIUrl":"10.1111/1475-6773.14347","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To illustrate the importance of a multidimensional view of disparities in quality of antidepressant medication management (AMM), as well as discriminating “within-facility” disparities from disparities that exist between facilities.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources and Study Setting</h3>\u0000 \u0000 <p>We used data from the Veterans Health Administration's (VA) Corporate Data Warehouse (CDW) which contains clinical and administrative data from VA facilities nationally.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Design</h3>\u0000 \u0000 <p>CDW data were used to measure five indicators of AMM quality, including the HEDIS Effective Acute-Phase and Effective Continuation-Phase measures. Mixed effects regression models were used to examine differences in quality indicators between racial/ethnic groups, controlling for other demographic and clinical factors. An adaptation of the Kitagawa-Blinder-Oaxaca (KBO) method was used to decompose mean differences in treatment quality between racial and ethnic groups into within- and between-facility effects.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Extraction Methods</h3>\u0000 \u0000 <p>Demographic, clinical, and health service utilization data were extracted for patients in fiscal year 2017 with a diagnosis of depression and a new start of an antidepressant medication.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Principal Findings</h3>\u0000 \u0000 <p>The decomposition of the overall differences between White and Black patients on receiving an initial 90-day prescription (46.7% vs. 32.7%), Effective Acute-Phase (79.7% vs. 66.8%), and Effective Continuation-Phase (64.0% vs. 49.6%) HEDIS measures revealed that most of the overall effects were “within-facility,” meaning that Black patients are less likely to meet these measures regardless of where they are treated. Although the overall magnitude of disparities between White and Hispanic patients on these three measures was very similar (46.7% vs. 32.7%; 79.7% vs. 69.2%; 64.0% vs. 53.6%), the differences were more attributable to Hispanic patients being treated in facilities with overall lower performance on these measures.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Discriminating within- and between-facility disparities and taking a multidimensional view of quality are essential to informing efforts to address disparities in AMM quality.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"59 5","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141536027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world impacts from a decade of Quality Enhancement Research Initiative-partnered projects to translate the Diabetes Prevention Program in the Veterans Health Administration 质量提升研究计划合作项目十年来对退伍军人健康管理局糖尿病预防计划的实际影响。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-05 DOI: 10.1111/1475-6773.14349
Laura J. Damschroder MS, MPH, Alison Hamilton PhD, MPH, Melissa M. Farmer PhD, Bevanne Bean-Mayberry MD, MHS, Caroline Richardson MD, Catherine Chanfreau PhD, Rebecca S. Oberman MSW, MPH, Rachel Lesser MPH, Jackie Lewis, Sue D. Raffa PhD, Micheal G. Goldstein MD, Sally Haskell MD, Erin Finley PhD, Tannaz Moin MD, MBA, MSHS
<div> <section> <h3> Objectives</h3> <p>To describe the impacts of four Veterans Health Administration (VA) Quality Enhancement Research Initiative (QUERI) projects implementing an evidence-based lifestyle intervention known as the Diabetes Prevention Program (DPP).</p> </section> <section> <h3> Data Sources and Study Setting</h3> <p>2012–2024 VA administrative and survey data.</p> </section> <section> <h3> Study Design</h3> <p>This is a summary of findings and impacts from four effectiveness-implementation projects focused on in-person and/or online DPP across VA sites.</p> </section> <section> <h3> Data Collection/Extraction Methods</h3> <p>Patient demographics, participation data, and key findings and impacts were summarized across reports from the VA Diabetes-Mellitus Quality Enhancement Research Initiative (QUERI-DM) Diabetes Prevention Program (VA DPP) Trial, QUERI-DM Online DPP Trial, the Enhancing Mental and Physical Health of Women through Engagement and Retention (EMPOWER) QUERI DPP Project, and EMPOWER 2.0 QUERI Program.</p> </section> <section> <h3> Principal Findings</h3> <p>Between 2012 and 2024, four VA QUERI studies enrolled 963 Veterans in DPP across 16 VA sites. All participants had overweight/obesity with one additional risk factor for type 2 diabetes (i.e., prediabetes, elevated risk score, or history of gestational diabetes) and 56% (<i>N</i> = 536) were women. In addition to enhancing the reach of and engagement in diabetes prevention services among Veterans, these projects resulted in three key impacts as follows: (1) informing the national redesign of VA MOVE! including recommendations to increase the number of MOVE! sessions and revise guidelines across 150+ VA sites, (2) enhancing the national evidence base to support online DPP delivery options with citations in national care guidelines outside VA, and (3) demonstrating the importance of gender-tailoring of preventive care services by and for women Veterans to enhance engagement in preventive services.</p> </section> <section> <h3> Conclusions</h3> <p>Over the past decade, the evolution of VA QUERI DPP projects increased the reach of and engagement in diabetes prevention services among Veterans, including women Veterans who have been harder to engage in lifestyle change programs in VA, and resulted in three key impacts informing type 2 diabetes and obesity prevention effo
目标:描述退伍军人健康管理局(VA)质量提升研究计划(QUERI)的四个项目在实施名为 "糖尿病预防计划"(DPP)的循证生活方式干预措施后产生的影响:数据收集/提取方法:患者人口统计数据、参与数据、主要发现和影响在退伍军人事务部糖尿病质量提升研究计划(QUERI-DM)糖尿病预防计划(VA DPP)试验、QUERI-DM在线DPP试验、通过参与和保留(EMPOWER)QUERI DPP项目和EMPOWER 2.0 QUERI计划的报告中进行了总结:2012 年至 2024 年间,退伍军人事务部的四项 QUERI 研究在退伍军人事务部的 16 个地点招募了 963 名退伍军人参加 DPP。所有参与者都患有超重/肥胖症,并有一个额外的 2 型糖尿病风险因素(即糖尿病前期、风险评分升高或妊娠糖尿病史),其中 56% (N = 536)为女性。除了扩大退伍军人糖尿病预防服务的覆盖面和参与度,这些项目还产生了以下三个关键影响:(1) 为退伍军人保健计划(VA MOVE!)的全国性重新设计提供了信息,包括建议增加 MOVE!课程的数量并修订 150 多个退伍军人保健站的指南;(2) 增强了全国性证据基础,以支持在线 DPP 交付选项,并在退伍军人保健计划以外的国家护理指南中引用;以及 (3) 证明了由女性退伍军人为女性退伍军人提供预防性护理服务的性别定制的重要性,以提高参与预防性服务的积极性:在过去的十年中,退伍军人事务部 QUERI DPP 项目的发展扩大了退伍军人(包括在退伍军人事务部较难参与生活方式改变计划的女性退伍军人)糖尿病预防服务的覆盖范围和参与度,并产生了三个关键影响,为退伍军人事务部内外的 2 型糖尿病和肥胖症预防工作提供了信息。
{"title":"Real-world impacts from a decade of Quality Enhancement Research Initiative-partnered projects to translate the Diabetes Prevention Program in the Veterans Health Administration","authors":"Laura J. Damschroder MS, MPH,&nbsp;Alison Hamilton PhD, MPH,&nbsp;Melissa M. Farmer PhD,&nbsp;Bevanne Bean-Mayberry MD, MHS,&nbsp;Caroline Richardson MD,&nbsp;Catherine Chanfreau PhD,&nbsp;Rebecca S. Oberman MSW, MPH,&nbsp;Rachel Lesser MPH,&nbsp;Jackie Lewis,&nbsp;Sue D. Raffa PhD,&nbsp;Micheal G. Goldstein MD,&nbsp;Sally Haskell MD,&nbsp;Erin Finley PhD,&nbsp;Tannaz Moin MD, MBA, MSHS","doi":"10.1111/1475-6773.14349","DOIUrl":"10.1111/1475-6773.14349","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objectives&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To describe the impacts of four Veterans Health Administration (VA) Quality Enhancement Research Initiative (QUERI) projects implementing an evidence-based lifestyle intervention known as the Diabetes Prevention Program (DPP).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Data Sources and Study Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;2012–2024 VA administrative and survey data.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Study Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This is a summary of findings and impacts from four effectiveness-implementation projects focused on in-person and/or online DPP across VA sites.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Data Collection/Extraction Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Patient demographics, participation data, and key findings and impacts were summarized across reports from the VA Diabetes-Mellitus Quality Enhancement Research Initiative (QUERI-DM) Diabetes Prevention Program (VA DPP) Trial, QUERI-DM Online DPP Trial, the Enhancing Mental and Physical Health of Women through Engagement and Retention (EMPOWER) QUERI DPP Project, and EMPOWER 2.0 QUERI Program.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Principal Findings&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Between 2012 and 2024, four VA QUERI studies enrolled 963 Veterans in DPP across 16 VA sites. All participants had overweight/obesity with one additional risk factor for type 2 diabetes (i.e., prediabetes, elevated risk score, or history of gestational diabetes) and 56% (&lt;i&gt;N&lt;/i&gt; = 536) were women. In addition to enhancing the reach of and engagement in diabetes prevention services among Veterans, these projects resulted in three key impacts as follows: (1) informing the national redesign of VA MOVE! including recommendations to increase the number of MOVE! sessions and revise guidelines across 150+ VA sites, (2) enhancing the national evidence base to support online DPP delivery options with citations in national care guidelines outside VA, and (3) demonstrating the importance of gender-tailoring of preventive care services by and for women Veterans to enhance engagement in preventive services.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Over the past decade, the evolution of VA QUERI DPP projects increased the reach of and engagement in diabetes prevention services among Veterans, including women Veterans who have been harder to engage in lifestyle change programs in VA, and resulted in three key impacts informing type 2 diabetes and obesity prevention effo","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"59 S2","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141536028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Processing and validation of inpatient Medicare Advantage data for use in hospital outcome measures. 处理和验证住院病人医疗保险优势数据,以用于医院结果测量。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-03 DOI: 10.1111/1475-6773.14350
Kelly A Kyanko, Kashika M Sahay, Yongfei Wang, Michelle Schreiber, Melissa Hager, Raquel Myers, Wanda Johnson, Jing Zhang, Bing-Jie Yen, Lisa G Suter, Elizabeth W Triche, Shu-Xia Li

Objective: To determine the feasibility of integrating Medicare Advantage (MA) admissions into the Centers for Medicare & Medicaid Services (CMS) hospital outcome measures through combining Medicare Advantage Organization (MAO) encounter- and hospital-submitted inpatient claims.

Data sources and study setting: Beneficiary enrollment data and inpatient claims from the Integrated Data Repository for 2018 Medicare discharges.

Study design: We examined timeliness of MA claims, compared diagnosis and procedure codes for admissions with claims submitted both by the hospital and the MAO (overlapping claims), and compared demographic characteristics and principal diagnosis codes for admissions with overlapping claims versus admissions with a single claim.

Data collection/extraction methods: We combined hospital- and MAO-submitted claims to capture MA admissions from all hospitals and identified overlapping claims. For admissions with only an MAO-submitted claim, we used provider history data to match the National Provider Identifier on the claim to the CMS Certification Number used for reporting purposes in CMS outcome measures.

Principal findings: After removing void and duplicate claims, identifying overlapped claims between the hospital- and MAO-submitted datasets, restricting claims to acute care and critical access hospitals, and bundling same admission claims, we identified 5,078,611 MA admissions. Of these, 76.1% were submitted by both the hospital and MAO, 14.2% were submitted only by MAOs, and 9.7% were submitted only by hospitals. Nearly all (96.6%) hospital-submitted claims were submitted within 3 months after a one-year performance period, versus 85.2% of MAO-submitted claims. Among the 3,864,524 admissions with overlapping claims, 98.9% shared the same principal diagnosis code between the two datasets, and 97.5% shared the same first procedure code.

Conclusions: Inpatient MA data are feasible for use in CMS claims-based hospital outcome measures. We recommend prioritizing hospital-submitted over MAO-submitted claims for analyses. Monitoring, data audits, and ongoing policies to improve the quality of MA data are important approaches to address potential missing data and errors.

目标:通过结合医疗保险优势组织(MAO)的遭遇和医院提交的住院病人索赔,确定将医疗保险优势组织(MA)的入院情况纳入医疗保险与医疗补助服务中心(CMS)医院结果测量的可行性:研究设计:我们检查了MA报销单的及时性,比较了由医院和MAO同时提交报销单(重叠报销单)的入院诊断和程序代码,并比较了重叠报销单入院与单一报销单入院的人口统计特征和主要诊断代码:我们将医院和 MAO 提交的索赔合并,以获取所有医院的 MA 住院病例,并确定重叠索赔。对于仅有 MAO 提交报销单的入院患者,我们使用医疗服务提供者历史数据将报销单上的全国医疗服务提供者标识符与 CMS 结果测量报告中使用的 CMS 认证号进行匹配:在剔除无效和重复索赔、识别医院和 MAO 提交的数据集之间的重叠索赔、将索赔限制在急症护理和危重病医院以及捆绑相同入院索赔后,我们确定了 5,078,611 例 MA 入院病人。其中,76.1% 由医院和 MAO 同时提交,14.2% 仅由 MAO 提交,9.7% 仅由医院提交。几乎所有(96.6%)由医院提交的报销申请都是在一年绩效期后的 3 个月内提交的,而由 MAO 提交的报销申请则为 85.2%。在 3,864,524 份索赔重叠的住院病例中,98.9% 的病例在两个数据集中共享相同的主要诊断代码,97.5% 的病例共享相同的第一个手术代码:住院医疗管理数据可用于基于 CMS 索赔的医院结果测量。我们建议在进行分析时优先考虑医院提交的索赔,而不是 MAO 提交的索赔。监测、数据审计和改善医疗保险数据质量的持续政策是解决潜在数据缺失和错误的重要方法。
{"title":"Processing and validation of inpatient Medicare Advantage data for use in hospital outcome measures.","authors":"Kelly A Kyanko, Kashika M Sahay, Yongfei Wang, Michelle Schreiber, Melissa Hager, Raquel Myers, Wanda Johnson, Jing Zhang, Bing-Jie Yen, Lisa G Suter, Elizabeth W Triche, Shu-Xia Li","doi":"10.1111/1475-6773.14350","DOIUrl":"https://doi.org/10.1111/1475-6773.14350","url":null,"abstract":"<p><strong>Objective: </strong>To determine the feasibility of integrating Medicare Advantage (MA) admissions into the Centers for Medicare & Medicaid Services (CMS) hospital outcome measures through combining Medicare Advantage Organization (MAO) encounter- and hospital-submitted inpatient claims.</p><p><strong>Data sources and study setting: </strong>Beneficiary enrollment data and inpatient claims from the Integrated Data Repository for 2018 Medicare discharges.</p><p><strong>Study design: </strong>We examined timeliness of MA claims, compared diagnosis and procedure codes for admissions with claims submitted both by the hospital and the MAO (overlapping claims), and compared demographic characteristics and principal diagnosis codes for admissions with overlapping claims versus admissions with a single claim.</p><p><strong>Data collection/extraction methods: </strong>We combined hospital- and MAO-submitted claims to capture MA admissions from all hospitals and identified overlapping claims. For admissions with only an MAO-submitted claim, we used provider history data to match the National Provider Identifier on the claim to the CMS Certification Number used for reporting purposes in CMS outcome measures.</p><p><strong>Principal findings: </strong>After removing void and duplicate claims, identifying overlapped claims between the hospital- and MAO-submitted datasets, restricting claims to acute care and critical access hospitals, and bundling same admission claims, we identified 5,078,611 MA admissions. Of these, 76.1% were submitted by both the hospital and MAO, 14.2% were submitted only by MAOs, and 9.7% were submitted only by hospitals. Nearly all (96.6%) hospital-submitted claims were submitted within 3 months after a one-year performance period, versus 85.2% of MAO-submitted claims. Among the 3,864,524 admissions with overlapping claims, 98.9% shared the same principal diagnosis code between the two datasets, and 97.5% shared the same first procedure code.</p><p><strong>Conclusions: </strong>Inpatient MA data are feasible for use in CMS claims-based hospital outcome measures. We recommend prioritizing hospital-submitted over MAO-submitted claims for analyses. Monitoring, data audits, and ongoing policies to improve the quality of MA data are important approaches to address potential missing data and errors.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Medicaid managed care on early detection of cancer: Evidence from mandatory Medicaid managed care program in Pennsylvania 医疗补助管理性护理对癌症早期发现的影响:宾夕法尼亚州强制医疗补助管理性医疗项目的证据。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-03 DOI: 10.1111/1475-6773.14348
Youngmin Kwon PhD, Eric T. Roberts PhD, Evan S. Cole PhD, Howard B. Degenholtz PhD, Bruce L. Jacobs MD, MPH, Lindsay M. Sabik PhD

Objective

To examine changes in late- versus early-stage diagnosis of cancer associated with the introduction of mandatory Medicaid managed care (MMC) in Pennsylvania.

Data Sources and Study Setting

We analyzed data from the Pennsylvania cancer registry (2010–2018) for adult Medicaid beneficiaries aged 21–64 newly diagnosed with a solid tumor. To ascertain Medicaid and managed care status around diagnosis, we linked the cancer registry to statewide hospital-based facility records collected by an independent state agency (Pennsylvania Health Care Cost Containment Council).

Study Design

We leveraged a natural experiment arising from county-level variation in mandatory MMC in Pennsylvania. Using a stacked difference-in-differences design, we compared changes in the probability of late-stage cancer diagnosis among those residing in counties that newly transitioned to mandatory managed care to contemporaneous changes among those in counties with mature MMC programs.

Data Collection/Extraction Methods

N/A.

Principal Findings

Mandatory MMC was associated with a reduced probability of late-stage cancer diagnosis (−3.9 percentage points; 95% CI: −7.2, −0.5; p = 0.02), particularly for screening-amenable cancers (−5.5 percentage points; 95% CI: −10.4, −0.6; p = 0.03). We found no significant changes in late-stage diagnosis among non-screening amenable cancers.

Conclusions

In Pennsylvania, the implementation of mandatory MMC for adult Medicaid beneficiaries was associated with earlier stage of diagnosis among newly diagnosed cancer patients with Medicaid, especially those diagnosed with screening-amenable cancers. Considering that over half of the sample was diagnosed with late-stage cancer even after the transition to mandatory MMC, Medicaid programs and managed care organizations should continue to carefully monitor receipt of cancer screening and design strategies to reduce barriers to guideline-concordant screening or diagnostic procedures.

目的:研究宾夕法尼亚州引入强制医疗补助管理式医疗(MMC)后,癌症晚期诊断与早期诊断的变化:研究宾夕法尼亚州引入强制性医疗补助管理性医疗(MMC)后,癌症晚期诊断与早期诊断的相关变化:我们分析了宾夕法尼亚州癌症登记处的数据(2010-2018 年),这些数据来自新诊断为实体瘤的 21-64 岁成年医疗补助受益人。为了确定诊断前后的医疗补助和管理式医疗状态,我们将癌症登记与独立的州立机构(宾夕法尼亚州医疗成本控制委员会)收集的全州医院设施记录联系起来:研究设计:我们利用了宾夕法尼亚州县级强制 MMC 变异所产生的自然实验。利用堆叠差分设计,我们比较了居住在新近过渡到强制管理性医疗的县的晚期癌症诊断概率的变化,以及居住在有成熟 MMC 项目的县的晚期癌症诊断概率的同期变化:主要发现强制管理医疗与癌症晚期诊断概率降低有关(-3.9 个百分点;95% CI:-7.2,-0.5;p = 0.02),尤其是可筛查癌症(-5.5 个百分点;95% CI:-10.4,-0.6;p = 0.03)。我们发现,在不适合筛查的癌症中,晚期诊断率没有明显变化:在宾夕法尼亚州,对成人医疗补助受益人实施强制性 MMC 与新诊断出的癌症患者(尤其是那些被诊断出患有可筛查癌症的患者)较早确诊有关。考虑到即使在过渡到强制性MMC后,仍有一半以上的样本被诊断为晚期癌症,医疗补助计划和管理性医疗机构应继续仔细监测癌症筛查的接受情况,并制定策略以减少与指南一致的筛查或诊断程序的障碍。
{"title":"Effects of Medicaid managed care on early detection of cancer: Evidence from mandatory Medicaid managed care program in Pennsylvania","authors":"Youngmin Kwon PhD,&nbsp;Eric T. Roberts PhD,&nbsp;Evan S. Cole PhD,&nbsp;Howard B. Degenholtz PhD,&nbsp;Bruce L. Jacobs MD, MPH,&nbsp;Lindsay M. Sabik PhD","doi":"10.1111/1475-6773.14348","DOIUrl":"10.1111/1475-6773.14348","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To examine changes in late- versus early-stage diagnosis of cancer associated with the introduction of mandatory Medicaid managed care (MMC) in Pennsylvania.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources and Study Setting</h3>\u0000 \u0000 <p>We analyzed data from the Pennsylvania cancer registry (2010–2018) for adult Medicaid beneficiaries aged 21–64 newly diagnosed with a solid tumor. To ascertain Medicaid and managed care status around diagnosis, we linked the cancer registry to statewide hospital-based facility records collected by an independent state agency (Pennsylvania Health Care Cost Containment Council).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Design</h3>\u0000 \u0000 <p>We leveraged a natural experiment arising from county-level variation in mandatory MMC in Pennsylvania. Using a stacked difference-in-differences design, we compared changes in the probability of late-stage cancer diagnosis among those residing in counties that newly transitioned to mandatory managed care to contemporaneous changes among those in counties with mature MMC programs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Collection/Extraction Methods</h3>\u0000 \u0000 <p>N/A.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Principal Findings</h3>\u0000 \u0000 <p>Mandatory MMC was associated with a reduced probability of late-stage cancer diagnosis (−3.9 percentage points; 95% CI: −7.2, −0.5; <i>p</i> = 0.02), particularly for screening-amenable cancers (−5.5 percentage points; 95% CI: −10.4, −0.6; <i>p</i> = 0.03). We found no significant changes in late-stage diagnosis among non-screening amenable cancers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>In Pennsylvania, the implementation of mandatory MMC for adult Medicaid beneficiaries was associated with earlier stage of diagnosis among newly diagnosed cancer patients with Medicaid, especially those diagnosed with screening-amenable cancers. Considering that over half of the sample was diagnosed with late-stage cancer even after the transition to mandatory MMC, Medicaid programs and managed care organizations should continue to carefully monitor receipt of cancer screening and design strategies to reduce barriers to guideline-concordant screening or diagnostic procedures.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"59 5","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospitals' collection and use of data to address social needs and social determinants of health. 医院收集和使用数据以满足社会需求和健康的社会决定因素。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-02 DOI: 10.1111/1475-6773.14341
Chelsea Richwine, Samantha Meklir

Objective: To assess differences in hospitals' collection and use of data on patients' health-related social needs (HRSN) by availability of programs or strategies in place to address patients' HRSN and social determinants of health (SDOH) of communities.

Data sources: The 2021 American Hospital Association Annual Survey and 2022 Information Technology (IT) Supplement.

Study design: This cross-sectional study described hospitals' engagement in screening and the availability of programs or strategies to address nine different HRSN. We assessed differences in screening rates and uses of data collected through screening among hospitals with and without programs or strategies in place to address HRSN or SDOH using Chi-squared tests of independence.

Data collection/extraction methods: Analyses were restricted to IT Supplement respondents with complete data for social needs questions asked in the Annual Survey (N = 1997).

Principal findings: In 2022, hospitals used social needs data collected through screening for various purposes including discharge planning and clinical decision-making at their hospital as well as to refer patients to needed resources and assess community-level needs. Hospitals with a program or strategy in place had higher rates of screening across all domains and higher rates of using of data collected through screening for uses involving exchange or coordination with external entities.

Conclusions: Collection of social needs data may help inform the development of programs or strategies to address HRSN and SDOH, which in turn can enable providers to screen for these needs and use the data in the near term for care delivery and in the long term to address community and population needs.

目的评估医院在收集和使用患者健康相关社会需求(HRSN)数据方面存在的差异,这些差异取决于是否有针对患者HRSN和社区健康社会决定因素(SDOH)的计划或策略:研究设计:这项横断面研究描述了医院参与筛查的情况,以及针对 9 种不同 HRSN 的计划或策略的可用性。我们使用独立的卡方检验法评估了实施和未实施HRSN或SDOH应对计划或策略的医院在筛查率和筛查数据使用方面的差异:分析仅限于在年度调查(N = 1997)中对社会需求问题提供完整数据的 IT 补充受访者:2022 年,医院将通过筛查收集到的社会需求数据用于各种目的,包括出院计划和医院的临床决策,以及将患者转介到所需的资源和评估社区层面的需求。制定了计划或策略的医院在所有领域的筛查率较高,将筛查收集的数据用于与外部实体交换或协调的比率也较高:结论:收集社会需求数据有助于为制定应对 HRSN 和 SDOH 的计划或策略提供信息,从而使医疗服务提供者能够对这些需求进行筛查,并在近期将数据用于提供医疗服务,在长期将数据用于满足社区和人口的需求。
{"title":"Hospitals' collection and use of data to address social needs and social determinants of health.","authors":"Chelsea Richwine, Samantha Meklir","doi":"10.1111/1475-6773.14341","DOIUrl":"https://doi.org/10.1111/1475-6773.14341","url":null,"abstract":"<p><strong>Objective: </strong>To assess differences in hospitals' collection and use of data on patients' health-related social needs (HRSN) by availability of programs or strategies in place to address patients' HRSN and social determinants of health (SDOH) of communities.</p><p><strong>Data sources: </strong>The 2021 American Hospital Association Annual Survey and 2022 Information Technology (IT) Supplement.</p><p><strong>Study design: </strong>This cross-sectional study described hospitals' engagement in screening and the availability of programs or strategies to address nine different HRSN. We assessed differences in screening rates and uses of data collected through screening among hospitals with and without programs or strategies in place to address HRSN or SDOH using Chi-squared tests of independence.</p><p><strong>Data collection/extraction methods: </strong>Analyses were restricted to IT Supplement respondents with complete data for social needs questions asked in the Annual Survey (N = 1997).</p><p><strong>Principal findings: </strong>In 2022, hospitals used social needs data collected through screening for various purposes including discharge planning and clinical decision-making at their hospital as well as to refer patients to needed resources and assess community-level needs. Hospitals with a program or strategy in place had higher rates of screening across all domains and higher rates of using of data collected through screening for uses involving exchange or coordination with external entities.</p><p><strong>Conclusions: </strong>Collection of social needs data may help inform the development of programs or strategies to address HRSN and SDOH, which in turn can enable providers to screen for these needs and use the data in the near term for care delivery and in the long term to address community and population needs.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141478016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation, intervention, and downstream costs for implementation of a multidisciplinary complex pain clinic in the Veterans Health Administration 退伍军人健康管理局多学科复杂疼痛诊所的实施、干预和下游成本。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-02 DOI: 10.1111/1475-6773.14345
Sarah I. Daniels PhD, Shayna Cave MS, Todd H. Wagner PhD, Taryn A. Perez MS, Sara N. Edmond PhD, William C. Becker MD, Amanda M. Midboe PhD
<div> <section> <h3> Objective</h3> <p>To determine the budget impact of implementing multidisciplinary complex pain clinics (MCPCs) for Veterans Health Administration (VA) patients living with complex chronic pain and substance use disorder comorbidities who are on risky opioid regimens.</p> </section> <section> <h3> Data Sources and Study Setting</h3> <p>We measured implementation costs for three MCPCs over 2 years using micro-costing methods. Intervention and downstream costs were obtained from the VA Managerial Cost Accounting System from 2 years prior to 2 years after opening of MCPCs.</p> </section> <section> <h3> Study Design</h3> <p>Staff at the three VA sites implementing MCPCs were supported by Implementation Facilitation. The intervention cohort was patients at MCPC sites who received treatment based on their history of chronic pain and risky opioid use. Intervention costs and downstream costs were estimated with a quasi-experimental study design using a propensity score-weighted difference-in-difference approach. The healthcare utilization costs of treated patients were compared with a control group having clinically similar characteristics and undergoing the standard route of care at neighboring VA medical centers. Cancer and hospice patients were excluded.</p> </section> <section> <h3> Data Collection/Extraction Methods</h3> <p>Activity-based costing data acquired from MCPC sites were used to estimate implementation costs. Intervention and downstream costs were extracted from VA administrative data.</p> </section> <section> <h3> Principal Findings</h3> <p>Average Implementation Facilitation costs ranged from $380 to $640 per month for each site. Upon opening of three MCPCs, average intervention costs per patient were significantly higher than the control group at two intervention sites. Downstream costs were significantly higher at only one of three intervention sites. Site-level differences were due to variation in inpatient costs, with some confounding likely due to the COVID-19 pandemic. This evidence suggests that necessary start-up investments are required to initiate MCPCs, with allocations of funds needed for implementation, intervention, and downstream costs.</p> </section> <section> <h3> Conclusions</h3> <p>Incorporating implementation, intervention, and downstream costs in this evaluation provides a thorough budget impact an
目标:确定为退伍军人健康管理局(VA)中患有复杂慢性疼痛和药物使用障碍合并症并接受高风险阿片类药物治疗的退伍军人实施多学科复杂疼痛诊所(MCPCs)对预算的影响:我们采用微观成本计算方法测算了三个 MCPC 两年内的实施成本。干预成本和下游成本来自退伍军人事务部管理成本会计系统(VA Managerial Cost Accounting System),时间跨度为 MCPC 启用前 2 年至启用后 2 年:研究设计:退伍军人事务部三个实施多用途社区医疗中心的地点的工作人员得到了实施促进的支持。研究设计:退伍军人事务部三个实施 MCPCs 的医疗点的工作人员得到了实施促进的支持。干预队列是 MCPC 医疗点中根据慢性疼痛和阿片类药物使用风险病史接受治疗的患者。干预成本和下游成本的估算采用了倾向得分加权差分法的准实验研究设计。将接受治疗的患者的医疗保健使用成本与临床特征相似且在邻近退伍军人医疗中心接受标准治疗的对照组进行了比较。数据收集/提取方法:数据收集/提取方法:使用从 MCPC 机构获得的基于活动的成本计算数据来估算实施成本。从退伍军人事务部的行政数据中提取干预成本和下游成本:每个站点的平均实施促进成本从每月 380 美元到 640 美元不等。三家 MCPC 开业后,在两个干预地点,每名患者的平均干预成本明显高于对照组。在三个干预地点中,只有一个地点的下游成本明显高于对照组。地点层面的差异是由于住院病人成本的差异造成的,而 COVID-19 大流行可能会造成一些混杂因素。这些证据表明,启动 MCPC 需要必要的启动投资,并需要为实施、干预和下游成本分配资金:本评估将实施、干预和下游成本纳入其中,提供了详尽的预算影响分析,决策者在考虑是否扩大有效计划时可加以利用。
{"title":"Implementation, intervention, and downstream costs for implementation of a multidisciplinary complex pain clinic in the Veterans Health Administration","authors":"Sarah I. Daniels PhD,&nbsp;Shayna Cave MS,&nbsp;Todd H. Wagner PhD,&nbsp;Taryn A. Perez MS,&nbsp;Sara N. Edmond PhD,&nbsp;William C. Becker MD,&nbsp;Amanda M. Midboe PhD","doi":"10.1111/1475-6773.14345","DOIUrl":"10.1111/1475-6773.14345","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To determine the budget impact of implementing multidisciplinary complex pain clinics (MCPCs) for Veterans Health Administration (VA) patients living with complex chronic pain and substance use disorder comorbidities who are on risky opioid regimens.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Data Sources and Study Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We measured implementation costs for three MCPCs over 2 years using micro-costing methods. Intervention and downstream costs were obtained from the VA Managerial Cost Accounting System from 2 years prior to 2 years after opening of MCPCs.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Study Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Staff at the three VA sites implementing MCPCs were supported by Implementation Facilitation. The intervention cohort was patients at MCPC sites who received treatment based on their history of chronic pain and risky opioid use. Intervention costs and downstream costs were estimated with a quasi-experimental study design using a propensity score-weighted difference-in-difference approach. The healthcare utilization costs of treated patients were compared with a control group having clinically similar characteristics and undergoing the standard route of care at neighboring VA medical centers. Cancer and hospice patients were excluded.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Data Collection/Extraction Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Activity-based costing data acquired from MCPC sites were used to estimate implementation costs. Intervention and downstream costs were extracted from VA administrative data.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Principal Findings&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Average Implementation Facilitation costs ranged from $380 to $640 per month for each site. Upon opening of three MCPCs, average intervention costs per patient were significantly higher than the control group at two intervention sites. Downstream costs were significantly higher at only one of three intervention sites. Site-level differences were due to variation in inpatient costs, with some confounding likely due to the COVID-19 pandemic. This evidence suggests that necessary start-up investments are required to initiate MCPCs, with allocations of funds needed for implementation, intervention, and downstream costs.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Incorporating implementation, intervention, and downstream costs in this evaluation provides a thorough budget impact an","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"59 S2","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving access to buprenorphine for rural veterans in a learning health care system 在学习型医疗保健系统中改善农村退伍军人获得丁丙诺啡的机会。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-02 DOI: 10.1111/1475-6773.14346
Jessica J. Wyse PhD, Katherine Mackey MD, Kim A. Kauzlarich PharmD, Benjamin J. Morasco PhD, Kathleen F. Carlson PhD, Adam J. Gordon MD, P. Todd Korthuis MD, Alison Eckhardt MA, Summer Newell PhD, Sarah S. Ono PhD, Travis I. Lovejoy PhD

Objective

To describe a learning health care system research process designed to increase buprenorphine prescribing for the treatment of opioid use disorder (OUD) in rural primary care settings within U.S. Department of Veterans Affairs (VA) treatment facilities.

Data Sources and Study Setting

Using national administrative data from the VA Corporate Data Warehouse, we identified six rural VA health care systems that had improved their rate of buprenorphine prescribing within primary care from 2015 to 2020 (positive deviants). We conducted qualitative interviews with leaders, clinicians, and staff involved in buprenorphine prescribing within primary care from these sites to inform the design of an implementation strategy.

Study Design

Qualitative interviews to inform implementation strategy development.

Data Collection/Extraction Methods

Interviews were audio-recorded, transcribed verbatim, and coded by a primary coder and secondary reviewer. Analysis utilized a mixed inductive/deductive approach. To develop an implementation strategy, we matched clinical needs identified within interviews with resources and strategies participants had utilized to address these needs in their own sites.

Principal Findings

Interview participants (n = 30) identified key clinical needs and strategies for implementing buprenorphine in rural, primary care settings. Common suggestions included the need for clinical mentorship or a consult service, buprenorphine training, and educational resources. Building upon interview findings and in partnership with a clinical team, we developed an implementation strategy composed of an engaging case-based training, an audit and feedback process, and educational resources (e.g., Buprenorphine Frequently Asked Questions, Rural Care Model Infographic).

Conclusions

We describe a learning health care system research process that leveraged national administrative data, health care provider interviews, and clinical partnership to develop an implementation strategy to encourage buprenorphine prescribing in rural primary care settings.

目的描述一个学习型医疗保健系统研究过程,该过程旨在增加美国退伍军人事务部(VA)治疗设施内农村初级医疗机构用于治疗阿片类药物使用障碍(OUD)的丁丙诺菲处方:利用退伍军人事务部企业数据仓库(VA Corporate Data Warehouse)中的全国行政数据,我们确定了六个农村退伍军人事务部医疗保健系统,这些系统在 2015 年至 2020 年期间提高了初级医疗保健中丁丙诺啡的处方率(正偏差)。我们对这些医疗机构中参与丁丙诺啡初级医疗处方的领导者、临床医生和工作人员进行了定性访谈,为实施策略的设计提供信息:研究设计:定性访谈,为实施策略的制定提供信息:对访谈进行录音、逐字转录,并由主要编码者和辅助审查者进行编码。分析采用归纳/演绎混合法。为了制定实施策略,我们将访谈中发现的临床需求与参与者在其工作场所为满足这些需求而使用的资源和策略进行了匹配:访谈参与者(n = 30)确定了在农村初级医疗机构实施丁丙诺啡的主要临床需求和策略。共同建议包括需要临床指导或咨询服务、丁丙诺啡培训和教育资源。在访谈结果的基础上,我们与一个临床团队合作,制定了一项实施策略,其中包括基于案例的培训、审核和反馈流程以及教育资源(如丁丙诺啡常见问题、农村医疗模式信息图):我们描述了一个学习型医疗保健系统研究过程,该过程利用国家行政数据、医疗保健提供者访谈和临床合作关系,制定了一项实施策略,以鼓励在农村初级医疗机构开具丁丙诺啡处方。
{"title":"Improving access to buprenorphine for rural veterans in a learning health care system","authors":"Jessica J. Wyse PhD,&nbsp;Katherine Mackey MD,&nbsp;Kim A. Kauzlarich PharmD,&nbsp;Benjamin J. Morasco PhD,&nbsp;Kathleen F. Carlson PhD,&nbsp;Adam J. Gordon MD,&nbsp;P. Todd Korthuis MD,&nbsp;Alison Eckhardt MA,&nbsp;Summer Newell PhD,&nbsp;Sarah S. Ono PhD,&nbsp;Travis I. Lovejoy PhD","doi":"10.1111/1475-6773.14346","DOIUrl":"10.1111/1475-6773.14346","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To describe a learning health care system research process designed to increase buprenorphine prescribing for the treatment of opioid use disorder (OUD) in rural primary care settings within U.S. Department of Veterans Affairs (VA) treatment facilities.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources and Study Setting</h3>\u0000 \u0000 <p>Using national administrative data from the VA Corporate Data Warehouse, we identified six rural VA health care systems that had improved their rate of buprenorphine prescribing within primary care from 2015 to 2020 (positive deviants). We conducted qualitative interviews with leaders, clinicians, and staff involved in buprenorphine prescribing within primary care from these sites to inform the design of an implementation strategy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Design</h3>\u0000 \u0000 <p>Qualitative interviews to inform implementation strategy development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Collection/Extraction Methods</h3>\u0000 \u0000 <p>Interviews were audio-recorded, transcribed verbatim, and coded by a primary coder and secondary reviewer. Analysis utilized a mixed inductive/deductive approach. To develop an implementation strategy, we matched clinical needs identified within interviews with resources and strategies participants had utilized to address these needs in their own sites.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Principal Findings</h3>\u0000 \u0000 <p>Interview participants (<i>n</i> = 30) identified key clinical needs and strategies for implementing buprenorphine in rural, primary care settings. Common suggestions included the need for clinical mentorship or a consult service, buprenorphine training, and educational resources. Building upon interview findings and in partnership with a clinical team, we developed an implementation strategy composed of an engaging case-based training, an audit and feedback process, and educational resources (e.g., Buprenorphine Frequently Asked Questions, Rural Care Model Infographic).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>We describe a learning health care system research process that leveraged national administrative data, health care provider interviews, and clinical partnership to develop an implementation strategy to encourage buprenorphine prescribing in rural primary care settings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"59 S2","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skilled nursing facility staffing shortages: Sources, strategies, and impacts on staff who stayed. 专业护理机构人员短缺:来源、策略以及对留下来的员工的影响。
IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-06-25 DOI: 10.1111/1475-6773.14355
Natalie E Leland, Rachel A Prusynski, Amanda D Shore, Michael P Cary, Jason Falvey, Tracy Mroz, Debra Saliba

Objective: To examine skilled nursing facility (SNF) staffing shortages across job roles during the COVID-19 pandemic. We aimed to capture the perspectives of leaders on the breadth of staffing shortages and their implications on staff that stayed throughout the pandemic in order to provide recommendations for policies and practices used to strengthen the SNF workforce moving forward.

Study setting and design: For this qualitative study, we engaged a purposive national sample of SNF leaders (n = 94) in one-on-one interviews between January 2021 and December 2022.

Data source and analytic sample: Using purposive sampling (i.e., Centers for Medicare & Medicaid quality rating, region, ownership) to capture variation in SNF organizations, we conducted in-depth, semi-structured qualitative interviews, guided a priori by the Institute of Medicine's Model of Healthcare System Framework. Interviews were conducted via phone, audio-recorded, and transcribed. Rigorous rapid qualitative analysis was used to identify emergent themes, patterns, and relationships.

Principal findings: SNF leaders consistently described staffing shortages spanning all job roles, including direct care (e.g., activities, nursing, social services), support services (e.g., laundry, food, environmental services), administrative staff, and leadership. Ascribed sources of shortages were multidimensional (e.g., competing salaries, family caregiving needs, burnout). The impact of shortages was felt by all staff that stayed. In addition to existing job duties, those remaining staff experienced re-distribution of essential day-to-day operational tasks (e.g., laundry) and allocation of new COVID-19 pandemic-related activities (e.g., screening). Cross-training was used to cover a wide range of job duties, including patient care.

Conclusions: Policies are needed to support SNF staff across roles beyond direct care staff. These policies must address the system-wide drivers perpetuating staffing shortages (i.e., pay differentials, burnout) and leverage strategies (i.e., cross-training, job role flexibility) that emerged from the pandemic to ensure a sustainable SNF workforce that can meet patient needs.

目的:研究熟练护理设施(SNF)在 COVID-19 大流行期间各岗位人员短缺的情况。我们旨在从领导者的角度了解人员短缺的广度及其对整个大流行期间留守员工的影响,从而为今后加强专业护理机构员工队伍的政策和实践提供建议:在这项定性研究中,我们在 2021 年 1 月至 2022 年 12 月期间对 SNF 领导者(n = 94)进行了有目的性的全国抽样一对一访谈:通过有目的的抽样(即医疗保险和医疗补助中心的质量评级、地区、所有权)来捕捉 SNF 组织的差异,我们进行了深入的半结构化定性访谈,事先以医学研究所的医疗保健系统框架模型为指导。访谈通过电话进行,并进行了录音和转录。采用严格的快速定性分析来确定新出现的主题、模式和关系:SNF领导一致描述了所有岗位的人员短缺情况,包括直接护理(如活动、护理、社会服务)、支持服务(如洗衣、食品、环境服务)、行政人员和领导。造成人员短缺的原因是多方面的(如薪酬竞争、家庭护理需求、职业倦怠)。所有留下来的工作人员都感受到了人员短缺的影响。除了现有的工作职责外,留下来的工作人员还经历了重新分配基本的日常业务任务(如洗衣)和分配新的 COVID-19 大流行病相关活动(如筛查)。交叉培训涵盖了广泛的工作职责,包括病人护理:除直接护理人员外,还需要制定相关政策,为 SNF 员工提供跨角色支持。这些政策必须解决造成人员短缺的全系统驱动因素(如薪酬差异、职业倦怠),并充分利用大流行病中出现的策略(如交叉培训、工作角色灵活性),以确保能够满足患者需求的可持续 SNF 员工队伍。
{"title":"Skilled nursing facility staffing shortages: Sources, strategies, and impacts on staff who stayed.","authors":"Natalie E Leland, Rachel A Prusynski, Amanda D Shore, Michael P Cary, Jason Falvey, Tracy Mroz, Debra Saliba","doi":"10.1111/1475-6773.14355","DOIUrl":"https://doi.org/10.1111/1475-6773.14355","url":null,"abstract":"<p><strong>Objective: </strong>To examine skilled nursing facility (SNF) staffing shortages across job roles during the COVID-19 pandemic. We aimed to capture the perspectives of leaders on the breadth of staffing shortages and their implications on staff that stayed throughout the pandemic in order to provide recommendations for policies and practices used to strengthen the SNF workforce moving forward.</p><p><strong>Study setting and design: </strong>For this qualitative study, we engaged a purposive national sample of SNF leaders (n = 94) in one-on-one interviews between January 2021 and December 2022.</p><p><strong>Data source and analytic sample: </strong>Using purposive sampling (i.e., Centers for Medicare & Medicaid quality rating, region, ownership) to capture variation in SNF organizations, we conducted in-depth, semi-structured qualitative interviews, guided a priori by the Institute of Medicine's Model of Healthcare System Framework. Interviews were conducted via phone, audio-recorded, and transcribed. Rigorous rapid qualitative analysis was used to identify emergent themes, patterns, and relationships.</p><p><strong>Principal findings: </strong>SNF leaders consistently described staffing shortages spanning all job roles, including direct care (e.g., activities, nursing, social services), support services (e.g., laundry, food, environmental services), administrative staff, and leadership. Ascribed sources of shortages were multidimensional (e.g., competing salaries, family caregiving needs, burnout). The impact of shortages was felt by all staff that stayed. In addition to existing job duties, those remaining staff experienced re-distribution of essential day-to-day operational tasks (e.g., laundry) and allocation of new COVID-19 pandemic-related activities (e.g., screening). Cross-training was used to cover a wide range of job duties, including patient care.</p><p><strong>Conclusions: </strong>Policies are needed to support SNF staff across roles beyond direct care staff. These policies must address the system-wide drivers perpetuating staffing shortages (i.e., pay differentials, burnout) and leverage strategies (i.e., cross-training, job role flexibility) that emerged from the pandemic to ensure a sustainable SNF workforce that can meet patient needs.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicaid coverage for gender-affirming surgery: A state-by-state review. 性别确认手术的医疗补助覆盖范围:逐州审查。
IF 3.4 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-06-17 DOI: 10.1111/1475-6773.14338
Jonnby S LaGuardia, Madeline G Chin, Sarah Fadich, Katarina B J Morgan, Halena H Ngo, Meiwand Bedar, Shahrzad Moghadam, Kelly X Huang, Christy Mallory, Justine C Lee

Objective: To systematically review Medicaid policies state-by-state for gender-affirming surgery coverage.

Data sources and study setting: Primary data were collected for each US state utilizing the LexisNexis legal database, state legislature publications, and Medicaid manuals.

Study design: A cross-sectional study evaluating Medicaid coverage for numerous gender-affirming surgeries.

Data collection/extraction methods: We previously reported on state health policies that protect gender-affirming care under Medicaid coverage. Building upon our prior work, we systematically assessed the 27 states with protective policies to determine coverage for each type of gender-affirming surgery. We analyzed Medicaid coverage for gender-affirming surgeries in four domains: chest, genital, craniofacial and neck reconstruction, and miscellaneous procedures. Medicaid coverage for each type of surgery was categorized as explicitly covered, explicitly noncovered, or not described.

Principal findings: Among the 27 states with protective Medicaid policies, 17 states (63.0%) provided explicit coverage for at least one gender-affirming chest procedure and at least one gender-affirming genital procedure, while only eight states (29.6%) provided explicit coverage for at least one craniofacial and neck procedure (p = 0.04). Coverage for specific surgical procedures within these three anatomical domains varied. The most common explicitly covered procedures were breast reduction/mastectomy and hysterectomy (n = 17, 63.0%). The most common explicitly noncovered surgery was reversal surgery (n = 12, 44.4%). Several states did not describe the specific surgical procedures covered; thus, final coverage rates are indeterminate.

Conclusions: In 2022, 52.9% of states had health policies that protected gender-affirming care under Medicaid; however, coverage for various gender-affirming surgical procedures remains both variable and occasionally unspecified. When specified, craniofacial and neck reconstruction is the least covered anatomical area compared with chest and genital reconstruction.

目标:系统地审查各州的性别确认手术医疗补助政策:系统审查各州在性别确认手术保险方面的医疗补助政策:利用 LexisNexis 法律数据库、州立法机构出版物和医疗补助手册收集美国各州的原始数据:研究设计:一项横断面研究,评估医疗补助计划对多种性别确认手术的覆盖情况:我们以前曾报道过在医疗补助计划覆盖范围内保护性别确认护理的州卫生政策。在之前工作的基础上,我们对 27 个实行保护政策的州进行了系统评估,以确定每种性别确认手术的承保范围。我们分析了医疗补助在四个领域对性别确认手术的承保范围:胸部、生殖器、颅面和颈部重建以及其他手术。每类手术的医疗补助覆盖范围分为明确覆盖、明确不覆盖或未说明:在 27 个制定了医疗补助保护政策的州中,有 17 个州(63.0%)明确承保了至少一种性别确认胸部手术和至少一种性别确认生殖器手术,而只有 8 个州(29.6%)明确承保了至少一种颅面和颈部手术(p = 0.04)。在这三个解剖学领域中,具体手术程序的承保范围各不相同。最常见的明确承保手术是乳房缩小/乳房切除术和子宫切除术(n = 17,63.0%)。最常见的明确不承保手术是翻转手术(12 例,44.4%)。有几个州没有说明承保的具体手术,因此最终的承保率并不确定:2022 年,52.9% 的州制定了医疗政策,保护医疗补助计划下的性别确认护理;然而,各种性别确认手术的承保范围仍然各不相同,有时甚至没有明确规定。在明确规定的情况下,与胸部和生殖器重建相比,颅面和颈部重建是受保最少的解剖学领域。
{"title":"Medicaid coverage for gender-affirming surgery: A state-by-state review.","authors":"Jonnby S LaGuardia, Madeline G Chin, Sarah Fadich, Katarina B J Morgan, Halena H Ngo, Meiwand Bedar, Shahrzad Moghadam, Kelly X Huang, Christy Mallory, Justine C Lee","doi":"10.1111/1475-6773.14338","DOIUrl":"https://doi.org/10.1111/1475-6773.14338","url":null,"abstract":"<p><strong>Objective: </strong>To systematically review Medicaid policies state-by-state for gender-affirming surgery coverage.</p><p><strong>Data sources and study setting: </strong>Primary data were collected for each US state utilizing the LexisNexis legal database, state legislature publications, and Medicaid manuals.</p><p><strong>Study design: </strong>A cross-sectional study evaluating Medicaid coverage for numerous gender-affirming surgeries.</p><p><strong>Data collection/extraction methods: </strong>We previously reported on state health policies that protect gender-affirming care under Medicaid coverage. Building upon our prior work, we systematically assessed the 27 states with protective policies to determine coverage for each type of gender-affirming surgery. We analyzed Medicaid coverage for gender-affirming surgeries in four domains: chest, genital, craniofacial and neck reconstruction, and miscellaneous procedures. Medicaid coverage for each type of surgery was categorized as explicitly covered, explicitly noncovered, or not described.</p><p><strong>Principal findings: </strong>Among the 27 states with protective Medicaid policies, 17 states (63.0%) provided explicit coverage for at least one gender-affirming chest procedure and at least one gender-affirming genital procedure, while only eight states (29.6%) provided explicit coverage for at least one craniofacial and neck procedure (p = 0.04). Coverage for specific surgical procedures within these three anatomical domains varied. The most common explicitly covered procedures were breast reduction/mastectomy and hysterectomy (n = 17, 63.0%). The most common explicitly noncovered surgery was reversal surgery (n = 12, 44.4%). Several states did not describe the specific surgical procedures covered; thus, final coverage rates are indeterminate.</p><p><strong>Conclusions: </strong>In 2022, 52.9% of states had health policies that protected gender-affirming care under Medicaid; however, coverage for various gender-affirming surgical procedures remains both variable and occasionally unspecified. When specified, craniofacial and neck reconstruction is the least covered anatomical area compared with chest and genital reconstruction.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Services Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1